{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:14:21Z","timestamp":1782526461724,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Overweight\/obesity is considered an independent risk factor for nephrolithiasis, but little is known about its effect on nephrolithiasis according to metabolic health status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>We aimed to investigate the association between various metabolic overweight phenotypes and the occurrence of nephrolithiasis. It also explores whether changes in these phenotypes over time influence the risk of nephrolithiasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>A total of 10,315 participants free of nephrolithiasis who underwent an annual health checkup from 2017 to 2022 were included in our prospective cohort study. They were categorized into four groups according to the presence of overweight and metabolic abnormalities (MA). The primary endpoint was the occurrence of renal stones. Multivariable Cox analysis was conducted to elucidate the relationship between metabolic overweight phenotypes and incident nephrolithiasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a median follow-up duration of 4.02\u00a0years, nephrolithiasis occurred in 1,468 (14.23%) participants. In the full cohort, we observed that the 5-year cumulative incidences of nephrolithiasis were highest in the metabolically healthy overweight (MHO) and metabolically abnormal overweight (MAO) groups. The hazard ratios (HRs) for nephrolithiasis, relative to metabolically healthy normal weight (MHNW), ranged from 1.19 (95% CI:1.03\u20131.37; MHO) to 1.32 (95% CI:1.15\u20131.51; MAO). Furthermore, individuals with persistent MHO throughout follow-up were at a 1.42-fold increased risk of nephrolithiasis (P\u2009&lt;\u20090.001), and 32.17% of individuals experienced changes in phenotype during follow-up. Among MAO subjects, those who transitioned to MHO and MHNW had a 26% and 45% lower risk of incident nephrolithiasis, respectively, compared to those who persisted in the MAO phenotype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Individuals in the MHO and MAO groups exhibit an elevated risk of incident nephrolithiasis in this prospective cohort study. A significant proportion of nephrolithiasis cases may be potentially preventable through the appropriate management of metabolic risk factors for MAO subjects.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-19229-8","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T08:01:44Z","timestamp":1721116904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\ufeffChanges in metabolic overweight phenotypes over time and risk of nephrolithiasis: a cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouyong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"9","key":"19229_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301\u201320.","journal-title":"World J Urol"},{"issue":"3","key":"19229_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.mayocp.2017.11.018","volume":"93","author":"W Kittanamongkolchai","year":"2018","unstructured":"Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, McCollough CH, Vrtiska TJ, Lieske JC, Rule AD. The changing incidence and presentation of urinary stones over 3 decades. Mayo Clin Proc. 2018;93(3):291\u20139.","journal-title":"Mayo Clin Proc"},{"issue":"2\u20133","key":"19229_CR3","first-page":"e86","volume":"12","author":"V Romero","year":"2010","unstructured":"Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2\u20133):e86\u201396.","journal-title":"Rev Urol"},{"issue":"1","key":"19229_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/bju.13828","volume":"120","author":"G Zeng","year":"2017","unstructured":"Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, Long Y, Ma J, Li Y, Wan SP, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120(1):109\u201316.","journal-title":"BJU Int"},{"issue":"1","key":"19229_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","volume":"62","author":"CD, Jr Scales","year":"2012","unstructured":"Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America P. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160\u20135.","journal-title":"Eur Urol"},{"issue":"4","key":"19229_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.23736\/S0393-2249.18.03113-2","volume":"70","author":"A Carbone","year":"2018","unstructured":"Carbone A, Al Salhi Y, Tasca A, Palleschi G, Fuschi A, De Nunzio C, Bozzini G, Mazzaferro S, Pastore AL. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018;70(4):393\u2013400.","journal-title":"Minerva Urol Nefrol"},{"issue":"1","key":"19229_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.urology.2011.12.065","volume":"80","author":"K Shahrour","year":"2012","unstructured":"Shahrour K, Tomaszewski J, Ortiz T, Scott E, Sternberg KM, Jackman SV, Averch TD. Predictors of immediate postoperative outcome of single-tract percutaneous nephrolithotomy. Urology. 2012;80(1):19\u201325.","journal-title":"Urology"},{"issue":"4","key":"19229_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/db06-1656","volume":"56","author":"L Fontana","year":"2007","unstructured":"Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010\u20133.","journal-title":"Diabetes"},{"issue":"2\u20132","key":"19229_CR9","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.3109\/17477166.2011.575149","volume":"6","author":"SA Taylor","year":"2011","unstructured":"Taylor SA, Hergenroeder AC. Waist circumference predicts increased cardiometabolic risk in normal weight adolescent males. Int J Pediatr Obes. 2011;6(2\u20132):e307\u2013311.","journal-title":"Int J Pediatr Obes"},{"issue":"1","key":"19229_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41043-019-0201-5","volume":"38","author":"T Shirasawa","year":"2019","unstructured":"Shirasawa T, Ochiai H, Yoshimoto T, Nagahama S, Kobayashi M, Ohtsu I, Sunaga Y, Kokaze A. Associations between normal weight central obesity and cardiovascular disease risk factors in Japanese middle-aged adults: a cross-sectional study. J Health Popul Nutr. 2019;38(1):46.","journal-title":"J Health Popul Nutr"},{"issue":"3","key":"19229_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/13685538.2016.1174987","volume":"19","author":"YC Lee","year":"2016","unstructured":"Lee YC, Huang SP, Juan YS, Huang TY, Liu CC. Impact of metabolic syndrome and its components on kidney stone in aging Taiwanese males. Aging Male. 2016;19(3):197\u2013201.","journal-title":"Aging Male"},{"issue":"1","key":"19229_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/13685538.2021.1998432","volume":"24","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Zhang Y, Zhang F, Wu C, Qin F, Yuan J. Prevalence and associated factors of metabolic syndrome in Chinese middle-aged and elderly population: a national cross-sectional study. Aging Male. 2021;24(1):148\u201359.","journal-title":"Aging Male"},{"issue":"2","key":"19229_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, Haring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"19229_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"CK Kramer","year":"2013","unstructured":"Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758\u201369.","journal-title":"Ann Intern Med"},{"issue":"12","key":"19229_CR15","doi-asserted-by":"publisher","first-page":"e066243","DOI":"10.1136\/bmjopen-2022-066243","volume":"12","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Zhang H, Zheng H, Yin H, Wang Y, Wang H, Gu L, Yin D. Association between serum uric acid\/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population. BMJ Open. 2022;12(12):e066243.","journal-title":"BMJ Open"},{"issue":"6","key":"19229_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373\u201392.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"19229_CR17","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.","journal-title":"Kidney stones Nat Rev Dis Primers"},{"issue":"11","key":"19229_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s10654-018-0426-4","volume":"33","author":"D Aune","year":"2018","unstructured":"Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033\u201347.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"19229_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1523-1755.2005.00516.x","volume":"68","author":"EN Taylor","year":"2005","unstructured":"Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230\u20135.","journal-title":"Kidney Int"},{"issue":"4","key":"19229_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41366-018-0140-z","volume":"43","author":"S Kim","year":"2019","unstructured":"Kim S, Chang Y, Yun KE, Jung HS, Kim I, Hyun YY, Lee KB, Joo KJ, Park HJ, Shin H, et al. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes (Lond). 2019;43(4):852\u201361.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"19229_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"19229_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2014.09.077","volume":"65","author":"JA Bell","year":"2015","unstructured":"Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101\u20132.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"19229_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1530\/EJE-15-0449","volume":"173","author":"M Hamer","year":"2015","unstructured":"Hamer M, Bell JA, Sabia S, Batty GD, Kivimaki M. Stability of metabolically healthy obesity over 8 years: the English Longitudinal Study of Ageing. Eur J Endocrinol. 2015;173(5):703\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"19229_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2265.2006.02474.x","volume":"64","author":"T Ronti","year":"2006","unstructured":"Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64(4):355\u201365.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"19229_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/13685538.2020.1713742","volume":"23","author":"M Inanir","year":"2020","unstructured":"Inanir M. Serum uric acid (SUA) in morbidly obese patients and its relationship with metabolic syndrome. Aging Male. 2020;23(5):1165\u20139.","journal-title":"Aging Male"},{"issue":"2","key":"19229_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1681\/ASN.2013111189","volume":"25","author":"JC Lieske","year":"2014","unstructured":"Lieske JC. New insights regarding the interrelationship of obesity, diet, physical activity, and kidney stones. J Am Soc Nephrol. 2014;25(2):211\u20132.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"19229_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/iju.12691","volume":"22","author":"Y Sasaki","year":"2015","unstructured":"Sasaki Y, Kohjimoto Y, Iba A, Matsumura N, Hara I. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome. Int J Urol. 2015;22(4):404\u20139.","journal-title":"Int J Urol"},{"issue":"1","key":"19229_CR28","doi-asserted-by":"publisher","first-page":"2195932","DOI":"10.1080\/13685538.2023.2195932","volume":"26","author":"Z Ye","year":"2023","unstructured":"Ye Z, Wu C, Xiong Y, Zhang F, Luo J, Xu L, Wang J, Bai Y. Obesity, metabolic dysfunction, and risk of kidney stone disease: a national cross-sectional study. Aging Male. 2023;26(1):2195932.","journal-title":"Aging Male"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-19229-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-19229-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-19229-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T08:02:32Z","timestamp":1721116952000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-19229-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["19229"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-19229-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations or the Declaration of Helsinki. The study was approved by the Institutional Review Board of Jiangsu Province Geriatric Hospital. All participants signed a written informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1898"}}